FreeStyle Libre - Clinical Studies, Flash Glucose Monitoring

Do you want to leave this page?

The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.

 

Do you want to leave this page?

 

Disclaimer

FreeStyle.abbott/in-en is a product-specific website intended for residents of India only. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence. 

The FreeStyle Libre system delivers important clinical benefits

FreeStyle Libre System Clinical Benefits

Lesser time in hypoglycemia

Both T1DM and T2DM FreeStyle Libre users spent significantly less time in hypoglycemia(70 mg/dl)16.

FreeStyle Libre System

Increase in Time in Range

1 hour increase in Time in Range in persons with diabetes on the FreeStyle Libre system16.

Reduction in hospital admissions and work absenteeism

66% reduction in hospital admissions with the FreeStyle Libre system over 1 year17.

FreeStyle Libre System for T1 and T2 Diabetes

58% reduction in work absenteeism17.

FreeStyle Libre System for T1 and T2 Diabetes

Improvement in quality of life

95% report a better understanding of his or her glucose fluctuation17.

FreeStyle Libre System

92% find it easier to regulate glucose around a meal17.

FreeStyle Libre System

References

16. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.

17. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care 2019;7:e000809. doi:10.1136/bmjdrc-2019-000809.

ADC-28471 v1.0 10/20

Cookie Policy

FreeStyle Libre uses cookies to give you the best website experience. By using our website, you consent to the use of cookies. More about our privacy policy

Choose country
Abbott Logo

The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings.

Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. Always read the label and use as directed.

For more information call Customer Service on 000 800 100 5780

© 2020 Abbott. All Rights Reserved. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners. Please read legal notice for further details

No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Healthcare Private Limited, except to identify the product or services of the company. This website and the information contained herein is intended for use by residents of India. The product images are for illustrative purposes only.

Disclaimer
www.FreeStyleLibre.co.in is a product-specific website intended only for residents of India. If you are resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.